Lv01
0 积分 2024-02-18 加入
Dynamics of molecular heterogeneity in high-risk luminal breast cancer—From intrinsic to adaptive subtyping
1小时前
已完结
Understanding the Spectrum of HER2 Status in Breast Cancer: From HER2-Positive to Ultra-Low HER2
6小时前
已完结
Targeting HER2 heterogeneity in breast cancer
7小时前
已完结
UK recommendations for HER2 assessment in breast cancer: an update
7小时前
已完结
152 Reevaluation of HER2 Heterogeneous Expression in Breast Cancer by Using Multi-FFPE Blocks
10天前
已完结
Stromal tumor infiltrating lymphocytes in hormone receptor positive/HER2 negative metastatic breast cancer
2个月前
已完结
Prognostic Implications of Magee Equation 3 and Residual Cancer Burden in patients receiving Neoadjuvant Chemotherapy for HR-Positive HER2-Negative Breast Cancer
2个月前
已完结
Computational Pathology for Accurate Prediction of Breast Cancer Recurrence: Development and Validation of a Deep Learning-based Tool
2个月前
已完结
Activity and Efficacy of Neoadjuvant Chemotherapy in Luminal-HER2 Negative Early Breast Cancer according to HER2 Score (Low vs Score 0): A Retrospective Study
2个月前
已关闭
152 Reevaluation of HER2 Heterogeneous Expression in Breast Cancer by Using Multi-FFPE Blocks
2个月前
已完结
皖公网安备34019202002308
